The cPass sVNT kit is the first “rapid” test kit that can detect neutralizing antibodies (NAbs), a specific type of antibody that has been shown to interfere with virus re-infection and may be a good indicator of potential immunity against Covid-19.
In a statement on Monday, March 30, DOST secretary Fortunato dela Pena said the field validation for the Covid-19 testing kits is ongoing and is expected to be finished by Wednesday, April 1.
